New Posts

Healthline Names AAFA Blog as One of the Best Blogs on Asthma for 2020

We are honored that the Asthma and Allergy Foundation of America’s blog has again been named one of the best asthma blogs by Healthline for 2020! Healthline is a health site with information on many health topics. We have received this honor since 2015 when we started our blog! Comment below to tell us what you want to see more of on our blog. We could not have received this honor without all of our supporters and members. Our blog will continue to bring you information about asthma and...

FDA Approves Dupixent® (Dupilumab) for Children Aged 6 to 11 Years With Moderate-to-Severe Atopic Dermatitis

The Asthma and Allergy Foundation of America (AAFA) is sharing this information from Regeneron Pharmaceuticals, Inc. and Sanofi to bring you the latest asthma and allergy news quickly. PRESS RELEASE FDA approves Dupixent® (dupilumab) as first biologic medicine for children aged 6 to 11 years with moderate-to-severe atopic dermatitis - In the pivotal trial, more than twice as many children achieved clear or almost clear skin and more than four times achieved itch reduction with Dupixent plus...

Letter to the FDA: Require Food Manufacturers to Post Substitutions

On May 22, 2020, the Food and Drug Administration (FDA) relaxed labeling guidelines for food companies . This is a temporary measure because of food supply issues due to COVID-19 (the new coronavirus). The Asthma and Allergy Foundation of America (AAFA) met with the FDA to talk about how this will affect the food allergy community. After the meeting, we organized a joint letter with other food allergy advocacy organizations to send to the FDA. The letter addresses the FDA’s short-term food...

Post
×
×
×
×